![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2016
Woelber, L.; Haeringer, N.; Eulenburg, C.; Donata, G.; Trillsch, F.; Burandt, E.; Schmalfeldt, B.; Mahner, S.; Mueller, V. und Prieske, K.
(2016):
Patterns of distant metastases in vulvar cancer.
In: International Journal of Gynecological Cancer, Bd. 26: S. 1164
Janni, W.; Schramm, A.; Friedl, T. W. P.; Schochter, E.; Huober, J.; Rack, B.; Alunni-Fabbroni, M.; Fasching, P. A.; Taran, F.-A.; Hortkopf, A.; Schneeweiss, A.; Mueller, V.; Aktas, B.; Krawczyk, N.; Pantel, K. und Fehm, T.
(2016):
Factors Predicting Discordance in HER2 Phenotype between Primary Tumor and Circulating Tumor Cells in Women with Metastatic Breast Cancer.
In: Oncology Research and Treatment, Bd. 39: S. 47
Tzschaschel, M.; Trapp, E.; Rack, B.; Messina, C.; Mueller, V.; Fehm, T.; Janni, W.; Loehberg, C.; Wimberger, P.; Kolberg, H.-C.; Uleer, C.; Brudler, O.; Sotiriou, C.; Pierga, J.-Y.; Piccart, M. und Ignatiadis, M.
(2016):
TREAT CTC: An innovative therapy approach to eliminate circulating tumor cells (CTCs).
In: Oncology Research and Treatment, Bd. 39: S. 55
Janni, W.; Rack, B.; Fasching, P.; Haeberle, L.; Friedl, T.; Tesch, H.; Lorenz, R.; Neugebauer, J.; Koch, J.; Jaeger, B.; Fehm, T.; Mueller, V.; Schneeweiß, A.; Lichtenegger, W.; Beckmann, M.; Scholz, C.; Pantel, K. und Trapp, E.
(2016):
Persistence of circulating tumor cells in high risk early breast cancer patients during follow-up care suggests poor prognosis - Results from the adjuvant SUCCESS A trial.
In: Cancer Research, Bd. 76
2008
Spanheimer, R.; Hoffmann, M.; Koegl, S.; Schmidt, S.; Pflueger, K. und Mueller, V.
(2008):
Differential regulation of Ota and Otb, two primary glycine betaine transporters in the methanogenic archaeon Methanosarcina mazei go1.
In: Journal of Molecular Microbiology and Biotechnology, Nr. 4: S. 255-263
[PDF, 380kB]